Markovic-Plese S - Search Results

1

Pathogenic features of CD4+CD28- T cells in immune disorders.

Broux B, Markovic-Plese S, Stinissen P, Hellings N. Broux B, et al. Trends Mol Med. 2012 Aug;18(8):446-53. doi: 10.1016/j.molmed.2012.06.003. Epub 2012 Jul 10. Trends Mol Med. 2012. PMID: 22784556 Review.

2

CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.

Broux B, Pannemans K, Zhang X, Markovic-Plese S, Broekmans T, Eijnde BO, Van Wijmeersch B, Somers V, Geusens P, van der Pol S, van Horssen J, Stinissen P, Hellings N. Broux B, et al. J Autoimmun. 2012 Feb;38(1):10-9. doi: 10.1016/j.jaut.2011.11.006. Epub 2011 Nov 26. J Autoimmun. 2012. PMID: 22123179

3

IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.

Seyedsadr M, Wang Y, Elzoheiry M, Shree Gopal S, Jang S, Duran G, Chervoneva I, Kasimoglou E, Wrobel JA, Hwang D, Garifallou J, Zhang X, Khan TH, Lorenz U, Su M, Ting JP, Broux B, Rostami A, Miskin D, Markovic-Plese S. Seyedsadr M, et al. Among authors: markovic plese s. Proc Natl Acad Sci U S A. 2023 Jun 27;120(26):e2221007120. doi: 10.1073/pnas.2221007120. Epub 2023 Jun 20. Proc Natl Acad Sci U S A. 2023. PMID: 37339207 Free PMC article.

4

CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. Markovic-Plese S, et al. J Clin Invest. 2001 Oct;108(8):1185-94. doi: 10.1172/JCI12516. J Clin Invest. 2001. PMID: 11602626 Free PMC article.

5

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

Zhang X, Jin J, Peng X, Ramgolam VS, Markovic-Plese S. Zhang X, et al. J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988. J Immunol. 2008. PMID: 18453621

6

Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response.

Zhang X, Markovic-Plese S. Zhang X, et al. Immunol Res. 2008;41(3):165-74. doi: 10.1007/s12026-008-8019-z. Immunol Res. 2008. PMID: 18484192 Review.

7

IFN-beta inhibits human Th17 cell differentiation.

Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S. Ramgolam VS, et al. J Immunol. 2009 Oct 15;183(8):5418-27. doi: 10.4049/jimmunol.0803227. Epub 2009 Sep 25. J Immunol. 2009. PMID: 19783688

8

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis.

Zhang X, Markovic-Plese S. Zhang X, et al. Clin Neurol Neurosurg. 2010 Sep;112(7):641-5. doi: 10.1016/j.clineuro.2010.04.020. Epub 2010 Jun 1. Clin Neurol Neurosurg. 2010. PMID: 20570038 Review.

9

Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.

Zhang X, Tao Y, Troiani L, Markovic-Plese S. Zhang X, et al. J Immunol. 2011 Sep 15;187(6):3431-7. doi: 10.4049/jimmunol.1100580. Epub 2011 Aug 19. J Immunol. 2011. PMID: 21856936

10

Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.

Zhang X, Tao Y, Wang J, Garcia-Mata R, Markovic-Plese S. Zhang X, et al. Eur J Immunol. 2013 Jan;43(1):281-9. doi: 10.1002/eji.201242566. Epub 2012 Dec 6. Eur J Immunol. 2013. PMID: 23076801 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters